Latest Epigenetics News

MDxHealth: Annual and Extraordinary General Shareholders’ MeetingRegulatory News: MDxHealth SA (NYSE Euronext: MDXH), a leading molecular diagnostic company that develops and commercializes epigenetic tests to support cancer treatment, held its Annual and Extraordinary General Meeting of shareholders in Zaventem today. The shareholders approved all agenda items of the Annual General Meeting, including th...

Oryzon Nominates Specific LSD1 Inhibitor as Drug Candidate to Enter Preclinical Development in Acute Leukemia and Other Hematological CancersOryzon announced today that it is entering preclinical development with its second drug candidate, a first-in-class specific Lysine Specific Demethylase 1 (LSD1) inhibitor for the treatment of hematological cancers. LSD1 inhibition reduced tumor load especially in acute leukemia models by targeting Leukemia Stem Cells, while normal myeloid progenitor cells were spared. Barcelona, Spain (PRWEB) May...

Miracle Botanicals Announces a Cure for the Poverty Mindset - Prosperity FormulaDrawing upon her understanding of the science of epigenetics coupled with her experience working with pure essential oils, Rev. Hope Johnson, founder of Miracle botanicals has created a Reiki charged Pure Essential Oil blend designed to shift consciousness into the flow of Prosperity and Abundance. Pahoa, HI (PRWEB) May 22, 2012 Never before have we lived in a time when it was so clearly evident...

MDxHealth’s ConfirmMDx™ for Prostate Cancer Test Helps to Identify Men Able to Avoid Repeat BiopsiesRegulatory News: MDxHealth SA (NYSE Euronext: MDXH), a leading molecular diagnostic company that develops and commercializes epigenetic tests to support cancer treatment, today announced it has presented data demonstrating that its epigenetic ConfirmMDx™ for Prostate Cancer test can aid urologists in identifying patients who may avoid a r...

EnVivo Pharmaceuticals Appoints Alfred Sandrock, M.D., Ph.D., to Board of DirectorsEnVivo Pharmaceuticals, a company dedicated to developing a broad range of novel central nervous system (CNS) therapies, today announced the appointment of Alfred Sandrock, M.D., Ph.D., to the company’s board of directors. Dr. Sandrock is senior vice president, development sciences and chief medical officer at

Australian Discovered Biomarkers Map Path to New Blood Test for Bowel CancerSAN DIEGO, May 20, 2012 /PRNewswire/ -- A team of Australian scientists has identified new genes that show identifiable changes in the blood of people with bowel cancer. The discovery has the potential to underpin a new cost-effective blood test that would signal the early stages of bowel cancer. This test could potentially save thousands of lives by supplementing existing screening programs and e...

Genetic Discovery Will Revolutionize Understanding Of Gene ExpressionOver the past decade, research in the field of epigenetics has revealed that chemically modified bases are abundant components of the human genome and has forced us to abandon the notion we've had since high school genetics that DNA consists of only...

Researchers identify novel base modification in RNAOver the past decade, research in the field of epigenetics has revealed that chemically modified bases are abundant components of the human genome and has forced us to abandon the notion we've had since high school genetics that DNA consists of only...

Up to 20 percent of human mRNA is routinely methylatedResearch in the field of epigenetics has revealed that chemically modified bases are abundant components of the human genome and has forced us to abandon the notion we’ve had since high school genetics that DNA consists of only four bases. Now,...

Rewriting Molecular Biology Textbooks…Again!Over the past decade, research in the field of epigenetics has revealed that chemically modified bases are abundant components of the human genome and has forced us to abandon the notion we’ve had since high school genetics that DNA consists of...

RNA modification influences thousands of genes: Revolutionizes understanding of gene expressionOver the past decade, research in the field of epigenetics has revealed that chemically modified bases are abundant components of the human genome and has forced us to abandon the notion we've had since high school genetics that DNA consists of only...

Researchers reveal an RNA modification influences thousands of genes(New York- Presbyterian Hospital/Weill Cornell Medical Center/Weill Cornell Medical College) Over the past decade, research in the field of epigenetics has revealed that chemically modified bases are abundant components of the human genome and has fo...

Epizyme Announces Appointment of Eric Hedrick, M.D., as Chief Medical OfficerEpizyme, Inc., a company leading the discovery and development of personalized therapeutics for patients with genetically-defined cancers, based on breakthroughs in the field of epigenetics, today announced that Dr. Eric Hedrick has joined the company as Chief Medical Officer. Dr. Hedrick brings extensive experience in both the development and...

Rubicon Genomics Launches ThruPLEX™ Family of Sample Preparation Products for Next Generation Sequencing ApplicationsANN ARBOR, Mich., May 16, 2012 /PRNewswire/ -- Rubicon Genomics, Inc., a leader in the development and commercialization of sample-specific pre-analytical processes to improve the performance and capabilities of DNA and RNA analytical platforms for research and clinical testing, today announced the launch of the first product in its innovative ThruPLEX™ family of sample preparation kits...

MDxHealth Provides First Quarter 2012 Business UpdateRegulatory News: MDxHealth SA (NYSE Euronext: MDXH), a leading molecular diagnostic company that develops and commercializes epigenetic tests to support cancer treatment, today issued its business update for the quarter ended March 31, 2012. Q1 2012 Highlights Continued Year-over-Year improvement of key financial...

Can a simple blood test really predict breast cancer?The Radio 4 Today programme heralded a day of wall to wall epigenetics. “Every now and then a new word emerges from scientific journals that lay people have to get used to. Such a word is...

Methylating Your Muscle DNAThere’s more to your DNA than your DNA. We are now becoming aware of the epigenome. While DNA controls you, your epigenome may help control your DNA, or rather, it can have an extensive impact on how your DNA is expressed. The epigenome consis...

Aircuity Congratulates Texas Children’s Hospital on Receiving the TurnKey Facility of the Year AwardAircuity, the smart airside efficiency company, today announced that its customer Texas Children’s Hospital has won the TurnKey Facility of the Year Award, presented at the TurnKey Conference in Baltimore, MD . The Jan and Dan Duncan Neurological Research Institute at Texas Children’s Hospital, a LEED Gold facility, was selected for its outstanding...

Manolis Kellis, Epigenetics, and the Future of Fighting DiseaseBio-IT World | BOSTON—Manolis Kellis, professor of computer science at MIT, addressed the Bio-IT World Conference on efforts to revolutionize the study of human disease by bridging the gap between genetics and epigenetics.

Environmental Epigenetics And Ovarian DiseaseWashington State University researchers have found that ovarian disease can result from exposures to a wide range of environmental chemicals and be inherited by future generations. WSU reproductive biologist Michael Skinner and his laboratory colleag...

A test to predict breast cancer many years before the disease is diagnosedUltimately the findings, in the journal Cancer Research, could lead to a simple blood test to screen women, they say. The test looks for how genes are altered by environmental factors like alcohol and hormones - a process known as epigenetics. One in...

CHR-3996 pill shows promise against advanced cancersScientists have shown that a brand new type of cancer pill that exploits the emerging field of epigenetics is safe for human use, according to a Phase I trial reported today in Clinical Cancer Research.

Epizyme to Participate in Upcoming Conferences in MayEpizyme, Inc., a company leading the discovery and development of personalized therapeutics for patients with genetically-defined cancers, based on breakthroughs in the field of epigenetics, today announced its participation in five upcoming conferences. Mr. Jason Rhodes, Executive Vice President & Chief Business Officer, wil...

Epigenetic Cancer Pills Are Safeâ�¨â�¨A brand new type of epigenetic cancer pill has been deemed safe for use in a Phase I trial according to Clinical Cancer Research. Epigenetics is the study of heritable changes in gene expression or cellular phenotype caused by mechanism...

Next-generation 'epigenetic' cancer pill shown to be safe in phase I trialScientists have shown that a brand new type of cancer pill that exploits the emerging field of epigenetics is safe for human use, according to Phase I trial results.

0 1 2 3 4 ›»

buy Epigenetics market research data and corporate reports now Advertisement